Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mookerjee

Showing results (411-420 of 461) with videos related to

Pageof 47
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 14, 2024
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trialLuis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, et al.
Journal of Clinical and Translational Research|March 22, 2019
FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver diseaseKiran V K Koelfat, Ruben G J Visschers, Caroline M J M Hodin, et al.
Journal of Primary Care & Community Health|February 17, 2024
Association of Risk Factors and Comorbidities With Chronic Pain in the Elderly PopulationNeil Mookerjee, Nicole Schmalbach, Gianna Antinori, et al.
Journal of Primary Care & Community Health|April 18, 2023
Comorbidities and Risk Factors Associated With Insomnia in the Elderly PopulationNeil Mookerjee, Nicole Schmalbach, Gianna Antinori, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Nature Medicine|June 8, 2019
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanomaPaolo Antonio Ascierto, Pier Francesco Ferrucci, Rosalie Fisher, et al.
Journal of Primary Care & Community Health|November 7, 2024
Association of Atrial Fibrillation with Insomnia in the Elderly PopulationJustin Nguyen, Neil Mookerjee, Prashant Koirala, et al.
Journal of Hepatology|December 3, 2014
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failureRajiv Jalan, Marco Pavesi, Faouzi Saliba, et al.
The Lancet. Oncology|April 16, 2016
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trialDavid Planchard, Tae Min Kim, Julien Mazieres, et al.
The New England Journal of Medicine|September 12, 2017
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated MelanomaGeorgina V Long, Axel Hauschild, Mario Santinami, et al.
Pageof 47

Showing results (411-420 of 461) with videos related to

Sort By:
Pageof 47
Lung Cancer (Amsterdam, Netherlands)|February 14, 2024
Canakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemotherapy and immunotherapy (CANOPY-2): A multicenter, randomized, double-blind, phase 3 trialLuis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, et al.
Journal of Clinical and Translational Research|March 22, 2019
FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver diseaseKiran V K Koelfat, Ruben G J Visschers, Caroline M J M Hodin, et al.
Journal of Primary Care & Community Health|February 17, 2024
Association of Risk Factors and Comorbidities With Chronic Pain in the Elderly PopulationNeil Mookerjee, Nicole Schmalbach, Gianna Antinori, et al.
Journal of Primary Care & Community Health|April 18, 2023
Comorbidities and Risk Factors Associated With Insomnia in the Elderly PopulationNeil Mookerjee, Nicole Schmalbach, Gianna Antinori, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
Nature Medicine|June 8, 2019
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanomaPaolo Antonio Ascierto, Pier Francesco Ferrucci, Rosalie Fisher, et al.
Journal of Primary Care & Community Health|November 7, 2024
Association of Atrial Fibrillation with Insomnia in the Elderly PopulationJustin Nguyen, Neil Mookerjee, Prashant Koirala, et al.
Journal of Hepatology|December 3, 2014
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failureRajiv Jalan, Marco Pavesi, Faouzi Saliba, et al.
The Lancet. Oncology|April 16, 2016
Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trialDavid Planchard, Tae Min Kim, Julien Mazieres, et al.
The New England Journal of Medicine|September 12, 2017
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated MelanomaGeorgina V Long, Axel Hauschild, Mario Santinami, et al.
Pageof 47